Healthcare Growth and Strategy Dental Implants Manufacturers

Healthcare Growth and Strategy Dental Implants Manufacturers

September 16, 2019
September 16, 2019

Share

For a Dental Implants Manufacturer, Stax Completed a Global Segmentation Study to Help the Company Focus Growth

THE SITUATION

  • For the portfolio company of a private equity firm, Stax sought to:
  • Identify and size actionable customer segments and determine the main factors that made each segment unique (such that they could align with the Company’s go-to-market strategy); complete a gap analysis of unmet/underserved needs; understand the growth rate of each segment to identify significant opportunities for the Company.
  • Defined the “adoption pathway” by determining how needs differed along the lifecycle: user mix changes between GP dentists and surgeons; trends in GP adoption of surgical procedures; drivers of/hindrances to adoption.
  • Map the referral patterns to highlight opportunities/pitfalls to growing the market when considering the “ecosystem” of dental implants which included GP dentists, referents, and manufacturers.


THE ASSIGNMENT

  • Stax went deep in collecting direct feedback from dentists, surgeons, and competitors in the dental implants space. We completed over 1,200 interviews across 11 countries targeting: GP dentists, periodontists, endodontists, prosthodontists, and implantologists via a combination of direct in-person interviews, phone interviews, and a web survey.
  • This data served as the fact base from which we completed our customer segmentation and profiling analysis as well as sizing the future market opportunity based on adoption intent.

THE BENEFITS

  • Stax work provided the Company with an in-depth understanding of unique customer segments with a clearly articulated go-to-market path for better serving each and driving incremental revenues on a country-by-country basis. Further, we were able to map the adoption pathway and drivers to answer for the company the opportunity vs. risk of having GP dentists performing implant surgery and the potential impact to the core surgeon business. We recommended a strategy to minimize channel conflict and leverage the referral network for all interested parties.

Read More

Stax Perspective: AI Tools for K-12 Education
By Miriam El-Baz July 9, 2025
With AI education now a national priority, Miriam El-Baz highlights in her latest article how investor focus is shifting to classroom adoption and long-term, responsible impact. Learn more.
Stax Provides Sell-side Support to Bow River Capital on its Sale of Progressive Roofing to TopBuild
July 8, 2025
Stax congratulates Bow River Capital on the successful sale of Progressive Roofing, provider commercial roofing installation services, to TopBuild. Click here to read more.
A Plan in Need of a Plan—Early Reflections on the New 10-Year Plan for the NHS
By Adam Thorpe July 4, 2025
Following the release of the NHS 10-Year Plan yesterday, Stax explores what it means for independent sector providers and healthcare investors. Read more.
Featured by Reuters: How China's new auto giants left GM, VW and Tesla in the dust
By Phil Dunne July 3, 2025
In this recent Reuters special report, Phil Dunne highlights why automakers struggle to match Chinese carmakers—but still hold key advantages, especially in Europe. Click here to read more.
Featured by Carta: Tariffs bring uncertainty—and opportunities—for PE and M&A
By Robert Lytle July 2, 2025
Senior Managing Director Robert Lytle was featured by Carta in their latest article, discussing the impacts of tariffs on M&A and portfolio companies. Click here to read more.
Stax Named Finalist for 2025 Real Deals Sustainable Investment Awards
July 1, 2025
Stax has been named a finalist in the 2025 Real Deals Sustainable Investment Awards, recognized in the category of Due Diligence Provider of the Year. Click here to learn about the award.
Show More